-+ 0.00%
-+ 0.00%
-+ 0.00%

Lytix Biopharma Appoints Chief Business Officer

MT Newswires·08/18/2026 05:02:42
Listen to the news
05:02 AM EDT, 08/18/2026 (MT Newswires) -- Lytix Biopharma (LYTIX.OL) said Tuesday it appointed Timothy Herpin as chief business officer on a fractional basis, with effect from Monday. Herpin will oversee the clinical-stage immuno-oncology company's global business development and partnering initiatives in the role.